SCHEMBL131292

SCHEMBL131292

CCCCC#C[O]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL131146 0.91
SCHEMBL128296 0.88 PTPN7 (0.52)
SCHEMBL131558 0.88 PTPN7 (0.52)
SCHEMBL126744 0.88 PTPN7 (0.52)
SCHEMBL448859 0.88 PTPN7 (0.52)
SCHEMBL170228 0.88 PTPN7 (0.52)
SCHEMBL448225 0.88 PTPN7 (0.52)
SCHEMBL448473 0.88 PTPN7 (0.52)
SCHEMBL453725 0.88 PTPN7 (0.52)
SCHEMBL130213 0.88 PTPN7 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1716 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117402124-A Aryl sulfonamide compound and anti-influenza application thereof 中国医学科学院医药生物技术研究所 2024-01-16 CN claimed
EP-1790639-B1 SPIROCYCLIC COMPOUNDS AND THEIR USE AS CXCR4-ANTAGONISTS ONO PHARMACEUTICAL CO (JP) 2014-03-26 EP claimed
US-7951816-B2 Compound containing basic group and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2011-05-31 US claimed
US-7906605-B2 Release coating compositions having improved release force profiles DOW CORNING CORPORATION (US) 2011-03-15 US claimed
US-20100144960-A1 Release Coating Compositions Having Improved Release Force Profiles DOW CORNING CORPORATION (US) 2010-06-10 US claimed
EP-1910487-A2 RELEASE COATING COMPOSITIONS HAVING IMPROVED RELEASE FORSE PROFILES Dow Corning Corporation (US) 2008-04-16 EP claimed
WO-2007015944-A2 RELEASE COATING COMPOSITIONS HAVING IMPROVED RELEASE FORSE PROFILES DOW CORNING CORPORATION (US) 2007-02-08 WO claimed
CN-118184702-A Antiviral prodrugs and uses thereof 上海柯君医药科技有限公司 2024-06-14 CN disclosed
CN-114989630-B Negative dichroic dye, preparation method thereof and display device 江苏创拓新材料有限公司 2024-05-28 CN disclosed
WO-2024106438-A1 AMIDE COMPOUNDS OR SALTS THEREOF, BACTERICIDAL AGENTS FOR AGRICULTURE AND HORTICULTURE CONTAINING SAID COMPOUNDS, AND METHOD OF USING SAME 日本農薬株式会社 2024-05-23 WO disclosed
CN-118044519-A Molecules having pesticidal utility, and intermediates, compositions and methods related thereto 科迪华农业科技有限责任公司 2024-05-17 CN disclosed
US-20240150292-A1 METHOD FOR PRODUCING AMINO ACID DERIVATIVES API CORPORATION (JP) 2024-05-09 US disclosed
US-20240125678-A1 COMPOUND, CELLULAR VESICLE STAIN, AND METHOD FOR FLUORESCENT STAINING OF CELLULAR VESICLES NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) 2024-04-18 US disclosed
US-4686227-A Imidazoisoquinoline compounds useful as anti-ulcerative agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-08-11 US disclosed
EP-0206251-A1 Haloacetamide compounds, process for production thereof, and use thereof as herbicide TOKUYAMA SODA KABUSHIKI KAISHA (JP) 1986-12-30 EP disclosed
EP-0165545-A2 Imidazoisoquinoline compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-12-27 EP disclosed
EP-0033255-B1 OXIMES DERIVED FROM ERYTHROMYCIN A, THEIR PREPARATION, THEIR APPLICATION IN PHARMACEUTICALS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1984-08-29 EP disclosed
US-4349545-A Novel erythromycin a derivatives ROUSSEL UCLAF (FR) 1982-09-14 US disclosed
EP-0033255-A1 Oximes derived from erythromycin A, their preparation, their application in pharmaceuticals and pharmaceutical compositions containing them ROUSSEL-UCLAF (FR) 1981-08-05 EP disclosed
US-4209623-A ANTIASTHMA BRISTOL-MYERS COMPANY (US) 1980-06-24 US disclosed